PineBridge Investments’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.77M | Sell |
135,201
-151,191
| -53% | -$8.21M | 0.05% | 247 |
|
|
2026
Q1 | $18M | Sell |
286,392
-28,054
| -9% | -$2.24M | 0.15% | 130 |
|
|
2025
Q4 | $30M | Buy |
314,446
+310,925
| +8,831% | +$30.5M | 0.22% | 90 |
|
|
2025
Q3 | $344K | Sell |
3,521
-49,365
| -93% | -$5.11M | ﹤0.01% | 510 |
|
|
2025
Q2 | $5.68M | Sell |
52,886
-8,188
| -13% | -$828K | 0.05% | 291 |
|
|
2025
Q1 | $6.16M | Sell |
61,074
-18,618
| -23% | -$1.87M | 0.05% | 300 |
|
|
2024
Q4 | $7.12M | Sell |
79,692
-135,652
| -63% | -$11.9M | 0.05% | 262 |
|
|
2024
Q3 | $18M | Buy |
215,344
+69,165
| +47% | +$5.45M | 0.14% | 165 |
|
|
2024
Q2 | $11.3M | Sell |
146,179
-243,404
| -62% | -$17.8M | 0.09% | 209 |
|
|
2024
Q1 | $26.7M | Buy |
389,583
+47,257
| +14% | +$3.04M | 0.21% | 115 |
|
|
2023
Q4 | $19.8M | Buy |
342,326
+36,824
| +12% | +$1.97M | 0.18% | 133 |
|
|
2023
Q3 | $16.1M | Buy |
305,502
+302,262
| +9,329% | +$15.9M | 0.18% | 132 |
|
|
2023
Q2 | $175K | Sell |
3,240
-86
| -3% | -$4.49K | ﹤0.01% | 542 |
|
|
2023
Q1 | $166K | Buy |
3,326
+796
| +31% | +$37.5K | ﹤0.01% | 503 |
|
|
2022
Q4 | $117K | Sell |
2,530
-308
| -11% | -$13.3K | ﹤0.01% | 507 |
|
|
2022
Q3 | $110K | Sell |
2,838
-2,001
| -41% | -$80.3K | ﹤0.01% | 510 |
|
|
2022
Q2 | $180K | Sell |
4,839
-25,141
| -84% | -$1.02M | ﹤0.01% | 494 |
|
|
2022
Q1 | $1.33M | Buy |
29,980
+991
| +3% | +$42.9K | 0.01% | 444 |
|
|
2021
Q4 | $1.23M | Sell |
28,989
-13,462
| -32% | -$566K | 0.01% | 483 |
|
|
2021
Q3 | $1.84M | Buy |
42,451
+42,198
| +16,679% | +$1.87M | 0.02% | 398 |
|
|
2021
Q2 | $11K | Sell |
253
-480
| -65% | -$20.2K | ﹤0.01% | 639 |
|
|
2021
Q1 | $28K | Sell |
733
-449
| -38% | -$17K | ﹤0.01% | 619 |
|
|
2020
Q4 | $42K | Buy |
+1,182
| New | +$42.6K | ﹤0.01% | 592 |
|
|
2020
Q2 | – | Sell |
-1,186
| Closed | -$39K | – | 651 |
|
|
2020
Q1 | $39K | Sell |
1,186
-1,749
| -60% | -$68.3K | ﹤0.01% | 576 |
|
|
2019
Q4 | $133K | Sell |
2,935
-47,272
| -94% | -$1.98M | ﹤0.01% | 886 |
|
|
2019
Q3 | $2.04M | Sell |
50,207
-8,688
| -15% | -$368K | 0.03% | 386 |
|
|
2019
Q2 | $2.53M | Buy |
58,895
+56,811
| +2,726% | +$2.19M | 0.04% | 317 |
|
|
2019
Q1 | $80K | Buy |
2,084
+666
| +47% | +$25.4K | ﹤0.01% | 881 |
|
|
2018
Q4 | $50K | Buy |
+1,418
| New | +$51.4K | ﹤0.01% | 965 |
|
|
2018
Q2 | – | Sell |
-1,464
| Closed | -$40K | – | 1086 |
|
|
2018
Q1 | $40K | Sell |
1,464
-8,804
| -86% | -$239K | ﹤0.01% | 1053 |
|
|
2017
Q4 | $255K | Buy |
+10,268
| New | +$283K | 0.01% | 888 |
|
|
2017
Q1 | – | Sell |
-975
| Closed | -$22K | – | 1126 |
|
|
2016
Q4 | $22K | Buy |
+975
| New | +$21.3K | ﹤0.01% | 1132 |
|
|
2016
Q3 | – | Sell |
-1,110
| Closed | -$26K | – | 1117 |
|
|
2016
Q2 | $26K | Sell |
1,110
-736
| -40% | -$15.9K | ﹤0.01% | 1050 |
|
|
2016
Q1 | $35K | Buy |
+1,846
| New | +$32.4K | ﹤0.01% | 985 |
|
|
2015
Q1 | – | Sell |
-617
| Closed | -$8K | – | 1098 |
|
|
2014
Q4 | $8K | Buy |
+617
| New | +$7.89K | ﹤0.01% | 1095 |
|
|
2013
Q3 | – | Sell |
-888,002
| Closed | -$8.23M | – | 1104 |
|
|
2013
Q2 | $8.23M | Buy |
+888,002
| New | +$7.53M | 0.26% | 115 |
|
Other funds holding BSX
PineBridge Investments's BSX Position: Q2 2026 in Review
PineBridge Investments reduced its Boston Scientific (BSX) stake by 53% in Q2 2026, selling an estimated $8.21M and leaving 135,201 shares worth $5.77M. The position accounts for 0.05% of the portfolio, ranked #247.
PineBridge Investments first reported a position in BSX in Q2 2013 and has held it in 36 quarters since. The position peaked at $30M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- PineBridge Investments held 135,201 shares of Boston Scientific worth $5.77M as of Q2 2026.
- PineBridge Investments sold 151,191 Boston Scientific shares in Q2 2026, an estimated $8.21M.
- Boston Scientific made up 0.05% of PineBridge Investments's portfolio in Q2 2026, its #247 holding.
- PineBridge Investments first reported a position in Boston Scientific in Q2 2013 and has held it in 36 quarters since.
- PineBridge Investments's Boston Scientific position peaked at $30M in Q4 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on PineBridge Investments's 13F filing for Q2 2026, filed 14 Aug 2026.